Oak Ridge Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $233K | Sell |
926
-230
| -20% | -$49.5K | 0.01% | 165 |
|
|
2026
Q1 | $251K | Sell |
1,156
-116
| -9% | -$25.7K | 0.02% | 168 |
|
|
2025
Q4 | $291K | Sell |
1,272
-222
| -15% | -$50.6K | 0.02% | 162 |
|
|
2025
Q3 | $346K | Buy |
1,494
+229
| +18% | +$46.6K | 0.02% | 160 |
|
|
2025
Q2 | $235K | Buy |
1,265
+1
| +0.1% | +$186 | 0.02% | 165 |
|
|
2025
Q1 | $265K | Hold |
1,264
| – | – | 0.02% | 156 |
|
|
2024
Q4 | $225K | Hold |
1,264
| – | – | 0.02% | 164 |
|
|
2024
Q3 | $250K | Buy |
1,264
+24
| +2% | +$4.48K | 0.02% | 149 |
|
|
2024
Q2 | $213K | Buy |
+1,240
| New | +$205K | 0.02% | 145 |
|
|
2024
Q1 | – | Sell |
-1,423
| Closed | -$221K | – | 144 |
|
|
2023
Q4 | $221K | Buy |
+1,423
| New | +$207K | 0.03% | 146 |
|
|
2023
Q2 | – | Sell |
-1,532
| Closed | -$244K | – | 148 |
|
|
2023
Q1 | $244K | Sell |
1,532
-231
| -13% | -$35.3K | 0.03% | 141 |
|
|
2022
Q4 | $285K | Hold |
1,763
| – | – | 0.04% | 141 |
|
|
2022
Q3 | $237K | Buy |
1,763
+323
| +22% | +$46.4K | 0.04% | 149 |
|
|
2022
Q2 | $221K | Sell |
1,440
-270
| -16% | -$41.3K | 0.03% | 151 |
|
|
2022
Q1 | $277K | Sell |
1,710
-3,570
| -68% | -$519K | 0.03% | 151 |
|
|
2021
Q4 | $715K | Sell |
5,280
-921
| -15% | -$109K | 0.06% | 147 |
|
|
2021
Q3 | $669K | Hold |
6,201
| – | – | 0.06% | 152 |
|
|
2021
Q2 | $698K | Hold |
6,201
| – | – | 0.06% | 155 |
|
|
2021
Q1 | $671K | Buy |
6,201
+1,732
| +39% | +$185K | 0.06% | 157 |
|
|
2020
Q4 | $479K | Hold |
4,469
| – | – | 0.04% | 174 |
|
|
2020
Q3 | $392K | Sell |
4,469
-35
| -0.8% | -$3.29K | 0.03% | 173 |
|
|
2020
Q2 | $442K | Sell |
4,504
-85
| -2% | -$7.48K | 0.04% | 166 |
|
|
2020
Q1 | $349K | Sell |
4,589
-402
| -8% | -$34.2K | 0.04% | 164 |
|
|
2019
Q4 | $442K | Sell |
4,991
-464
| -9% | -$38.5K | 0.03% | 170 |
|
|
2019
Q3 | $413K | Sell |
5,455
-5,851
| -52% | -$401K | 0.03% | 168 |
|
|
2019
Q2 | $822K | Sell |
11,306
-1,456
| -11% | -$114K | 0.06% | 142 |
|
|
2019
Q1 | $1.03M | Sell |
12,762
-73,460
| -85% | -$6.01M | 0.07% | 140 |
|
|
2018
Q4 | $7.95M | Sell |
86,222
-12,644
| -13% | -$1.11M | 0.57% | 68 |
|
|
2018
Q3 | $9.35M | Sell |
98,866
-4,041
| -4% | -$383K | 0.52% | 81 |
|
|
2018
Q2 | $9.53M | Sell |
102,907
-4,309
| -4% | -$421K | 0.54% | 82 |
|
|
2018
Q1 | $10.1M | Buy |
+107,216
| New | +$11.8M | 0.56% | 72 |
|
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Oak Ridge Investments's ABBV Position: Q2 2026 in Review
Oak Ridge Investments reduced its AbbVie (ABBV) stake by 20% in Q2 2026, selling an estimated $49.5K and leaving 926 shares worth $233K. The position accounts for 0.01% of the portfolio, ranked #165.
Oak Ridge Investments first reported a position in ABBV in Q1 2018 and has held it in 31 quarters since. The position peaked at $10.1M in Q1 2018. 1,339 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Oak Ridge Investments held 926 shares of AbbVie worth $233K as of Q2 2026.
- Oak Ridge Investments sold 230 AbbVie shares in Q2 2026, an estimated $49.5K.
- AbbVie made up 0.01% of Oak Ridge Investments's portfolio in Q2 2026, its #165 holding.
- Oak Ridge Investments first reported a position in AbbVie in Q1 2018 and has held it in 31 quarters since.
- Oak Ridge Investments's AbbVie position peaked at $10.1M in Q1 2018.
- 1,339 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Oak Ridge Investments's 13F filing for Q2 2026, filed 21 Jul 2026.